The inhibition of beta-lactamases from gram-negative bacteria by clavulanic acid.
about
Beta-lactamase inhibitors from laboratory to clinicChemistry and biosynthesis of clavulanic acid and other clavamsFluorescent TEM-1 β-lactamase with wild-type activity as a rapid drug sensor for in vitro drug screening.Randomized comparative study of amoxicillin-clavulanic acid and co-trimoxazole in the treatment of acute urinary tract infections in adultsEvidence for myosin motors on organelles in squid axoplasm.Evolution of an enzyme activity: crystallographic structure at 2-A resolution of cephalosporinase from the ampC gene of Enterobacter cloacae P99 and comparison with a class A penicillinase.Beta-lactams and beta-lactamase-inhibitors in current- or potential-clinical practice: a comprehensive update.The potential use of mechanism-based enzyme inactivators in medicine.Beta-lactamases: molecular studies.beta-Lactamase inhibitors.A practical look at the clinical usefulness of the beta-lactam/beta-lactamase inhibitor combinations.Interactions between active-site-serine beta-lactamases and mechanism-based inactivators: a kinetic study and an overview.Kinetic studies on inactivation of Citrobacter freundii cephalosporinase by sulbactam.The diversity of the catalytic properties of class A beta-lactamases.Novel carbapenem derivative SF2103A: studies on the mode of beta-lactamase inactivation.Interaction of clavulanate with the beta-lactamases of Streptomyces albus G and Actinomadura R39.Kinetic and physical studies of beta-lactamase inhibition by a novel penem, BRL 42715.
P2860
Q24617277-E39DD84A-359F-49D0-9A13-9521516C40F2Q28247865-102A5650-43F4-4879-9A36-4698B4AE3BBEQ34139889-952B4B20-E083-4D70-9A9F-2BAEBA844E3CQ35572627-DBB22B2A-F0D5-42E1-AB03-6ADC8C599C04Q36698185-6E0EDD0C-482A-454C-8EF4-15C460EEBFFCQ36698566-1D3FCAAF-69B8-4827-942B-D0ACEBA58946Q37514259-B1F75ABD-BD39-44A3-B6D9-01026F94DF1EQ39568018-1ECABC32-1949-4CE1-A49C-6E2599CCE240Q39840462-3F861CB0-9FA0-475D-9503-9BC8D5AFC68BQ40164014-F89B7336-4DDA-46C4-AA66-2E225BD139DEQ41189315-B8357567-A9B6-4517-A2F9-2DBC01486A6CQ41968772-A7EED94C-11BE-4358-AFA9-78C66F67B79FQ41971598-72554B07-41C7-43DB-9177-3B6307C73ADBQ41981406-9F25C31A-381E-4E8E-AF5D-0C6454A00570Q42115502-49B7451E-37DB-4C08-BA4B-73916016EED3Q42140880-35944A5E-AF40-40C0-BF5E-58C1A572EBC1Q42831248-5A8504EF-784F-430F-94A1-D04E2D45A7E4
P2860
The inhibition of beta-lactamases from gram-negative bacteria by clavulanic acid.
description
1981 nî lūn-bûn
@nan
1981年の論文
@ja
1981年学术文章
@wuu
1981年学术文章
@zh-cn
1981年学术文章
@zh-hans
1981年学术文章
@zh-my
1981年学术文章
@zh-sg
1981年學術文章
@yue
1981年學術文章
@zh
1981年學術文章
@zh-hant
name
The inhibition of beta-lactamases from gram-negative bacteria by clavulanic acid.
@en
The inhibition of beta-lactamases from gram-negative bacteria by clavulanic acid.
@nl
type
label
The inhibition of beta-lactamases from gram-negative bacteria by clavulanic acid.
@en
The inhibition of beta-lactamases from gram-negative bacteria by clavulanic acid.
@nl
prefLabel
The inhibition of beta-lactamases from gram-negative bacteria by clavulanic acid.
@en
The inhibition of beta-lactamases from gram-negative bacteria by clavulanic acid.
@nl
P2860
P356
P1433
P1476
The inhibition of beta-lactamases from gram-negative bacteria by clavulanic acid.
@en
P2093
P2860
P304
P356
10.1042/BJ1990779
P407
P577
1981-12-01T00:00:00Z